Ronald K. Yamamoto
Gründer bei Oxular Ltd.
Profil
Ronald K.
Yamamoto was the founder of Vitaphore Corp.
(founded in 1985) and Oxular Ltd.
(founded in 2014), where he held the titles of VP, Chief Executive & Scientific Officer and Chief Scientific Officer & Director, respectively.
He previously held the position of President & Chief Executive Officer at POINT Biomedical Corp.
and served as a Director at Biocept, Inc., iScience Interventional Corp., and Halscion, Inc. Mr. Yamamoto received his graduate degree from the University of Southern California and Clemson University, and his undergraduate degree from the California Institute of Technology.
Aktive Positionen von Ronald K. Yamamoto
| Unternehmen | Position | Beginn |
|---|---|---|
Oxular Ltd.
 Oxular Ltd. BiotechnologyHealth Technology Oxular Ltd. engages in research and experimental development on biotechnology. The firm develops retinal treatments to access specific small spaces in the eye and to provide drug distribution to tissues involved in retinal diseases. The company was founded by Tom Cavanagh and Ronald K. Yamamoto in 2014 and is headquartered in Oxford, the United Kingdom. | Gründer | 01.01.2014 |
Ehemalige bekannte Positionen von Ronald K. Yamamoto
| Unternehmen | Position | Ende |
|---|---|---|
| BIOCEPT, INC. | Direktor/Vorstandsmitglied | - |
Halscion, Inc.
 Halscion, Inc. Medical SpecialtiesHealth Technology Halscion, Inc. developed technologies and biomaterial to treat dermatological conditions. It offered a device for the reduction in the appearance of scars resulting from acute surgical wounds. The company was founded by Charles E. Larsen, Thomas D. Weldon, and Gerard van Hamel Platerink in 2005 and was headquartered in Suwanee, GA. | Direktor/Vorstandsmitglied | - |
| Vitaphore Corp. | Gründer | - |
POINT Biomedical Corp.
 POINT Biomedical Corp. Pharmaceuticals: MajorHealth Technology POINT Biomedical Corp. develops biomedical-imaging products. It manufactures products for diagnostic, molecular imaging, and drug delivery applications based on biSphere technology. The company was founded in 1996 and is headquartered in San Carlos, CA. | Präsident | - |
iScience Interventional Corp.
 iScience Interventional Corp. Medical/Nursing ServicesHealth Services iScience Interventional Corp. discovers and develops microcatheter and imaging technologies that enable ophthalmologists to deliver site-specific ocular therapies. It encompasses microcatheter-based therapies designed to access anatomical structures within the eye to aspirate ocular fluids or deliver sterile ophthalmic solutions to the eye. The firm addresses the previously unmet need for treatment of sight-threatening diseases with the innovative, minimally invasive iCath™ procedures. The company was founded by Michael F. Nash and Stan Conston in 1999 and is headquartered in Menlo Park, CA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Ronald K. Yamamoto
| University of Southern California | Graduate Degree |
| Clemson University | Graduate Degree |
| California Institute of Technology | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BIOCEPT, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
POINT Biomedical Corp.
POINT Biomedical Corp. Pharmaceuticals: MajorHealth Technology POINT Biomedical Corp. develops biomedical-imaging products. It manufactures products for diagnostic, molecular imaging, and drug delivery applications based on biSphere technology. The company was founded in 1996 and is headquartered in San Carlos, CA. | Health Technology |
iScience Interventional Corp.
iScience Interventional Corp. Medical/Nursing ServicesHealth Services iScience Interventional Corp. discovers and develops microcatheter and imaging technologies that enable ophthalmologists to deliver site-specific ocular therapies. It encompasses microcatheter-based therapies designed to access anatomical structures within the eye to aspirate ocular fluids or deliver sterile ophthalmic solutions to the eye. The firm addresses the previously unmet need for treatment of sight-threatening diseases with the innovative, minimally invasive iCath™ procedures. The company was founded by Michael F. Nash and Stan Conston in 1999 and is headquartered in Menlo Park, CA. | Health Services |
Halscion, Inc.
Halscion, Inc. Medical SpecialtiesHealth Technology Halscion, Inc. developed technologies and biomaterial to treat dermatological conditions. It offered a device for the reduction in the appearance of scars resulting from acute surgical wounds. The company was founded by Charles E. Larsen, Thomas D. Weldon, and Gerard van Hamel Platerink in 2005 and was headquartered in Suwanee, GA. | Health Technology |
| Vitaphore Corp. | |
Oxular Ltd.
Oxular Ltd. BiotechnologyHealth Technology Oxular Ltd. engages in research and experimental development on biotechnology. The firm develops retinal treatments to access specific small spaces in the eye and to provide drug distribution to tissues involved in retinal diseases. The company was founded by Tom Cavanagh and Ronald K. Yamamoto in 2014 and is headquartered in Oxford, the United Kingdom. | Health Technology |